Migrafen (Ibuprofen Bp)

Ibuprofen works by reversibly blocking the cyclo‑oxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. Prostaglandins mediate pain, fever, and inflammation, so their reduction leads to decreased sensation of pain, lower body temperature, and diminished swelling at the site of inflammation.

The appropriate dose of Migrafen is determined by the prescribing clinician based on the individual’s age, weight, medical condition, and response to therapy. Healthcare providers select the strength, frequency, and duration that best address the patient’s specific needs while minimizing potential risks.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and clinical circumstances. Generally, ibuprofen is avoided in the third trimester because it may affect fetal cardiovascular function. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider before using Migrafen.

To request Migrafen, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a quotation, confirming availability, arranging shipping (including any required temperature control), and handling import documentation.

Migrafen (ibuprofen) shares the core anti‑inflammatory, analgesic, and antipyretic properties of the NSAID class. Compared with some NSAIDs such as naproxen, ibuprofen has a shorter half‑life, which may allow more flexible dosing but may also require more frequent administration. Its safety profile is well‑characterized, though gastrointestinal and renal considerations are similar across the class.

Migrafen should be stored at ambient temperature, ideally below 25 °C, in its original container to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments. No special refrigeration is required for this oral formulation.

Migrafen is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. The tablet should be swallowed whole and not chewed or crushed unless specifically instructed by a healthcare professional.

Serious adverse events associated with ibuprofen include gastrointestinal bleeding or ulceration, severe renal impairment, and rare hypersensitivity reactions such as Stevens‑Johnson syndrome or anaphylaxis. Patients should seek immediate medical attention if they notice black stools, unexplained bruising, sudden swelling, rash, or difficulty breathing while using Migrafen.

Migrafen should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, or uncontrolled hypertension. It is also contraindicated in patients receiving certain anticoagulants, lithium, or high‑dose methotrexate without close medical supervision.